atosiban

SynDRA canonical compound SYN0041783 — structure-anchored drug synonym record

Clinical phase	Launched
Primary target(s)	AVPR1A \| AVPR1B \| AVPR2 \| OXT \| OXTR
Mechanism of action	oxytocin receptor antagonist
Indication	angina pectoris \| hyperlipidemia \| myocardial infarction \| premature labor \| stroke
Disease area	Birth \| cardiology \| endocrinology \| neurology/psychiatry

All known targets

atosiban acetate
Antocin II
antocin
tractocil
tractocile
Antocile
Antocin
Antocin ii
Tractocil
CAP-449
CAP-476
CAP-581
F-314
ORF-22164
RW-22164
RWJ-22164
Tractocile
Atosiban acetate
UNII-081D12SI0Z
ORF 22164
CHEMBL382301
1-Deamino-2D-tyr-(OEt)-4-thr-8-orn-oxytocin
dTVT
081D12SI0Z
1-Deamino-2-D-Tyr-(O-ethyl)-4-Thr-8-ornoxytocin
1-(3-Mercaptopropanoic acid)-2-(O-ethyl-D-tyrosine)-4-L-threonine-8-L-ornithineoxytocin
NCGC00165718-01
Atosibanum [INN-Latin]
deTVT
Atosibanum
Atosiban [USAN:INN:BAN]
RWJ22164
1-(3-Mercaptopropionic acid)-2-(3-(p-ethoxyphenyl)-D-alanine)-4-L-threonine-8-L-ornithineox
Orf-22164
DTXCID4028917
RefChem:115452
1-deamino-2-Tyr(OEt)-4-Thr-8-Orn-oxytocin